Meredith Kaya | executive |
Cedric Francois | executive |
Adam Townsend | executive |
Caroline Baumal | executive |
Timothy Sullivan | executive |
Jonathan Miller | analyst |
Tazeen Ahmad | analyst |
Salveen Richter | analyst |
Yigal Nochomovitz | analyst |
Colleen Hanley | analyst |
Philip Nadeau | analyst |
Eliana Merle | analyst |
Annabel Samimy | analyst |
François Brisebois | analyst |
Joseph Stringer | analyst |
Douglas Tsao | analyst |
Graig Suvannavejh | analyst |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Apellis Pharmaceuticals First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised today's call is being recorded. I will now turn the call over to your speaker host, Meredith Kaya, Senior Vice President, Investor Relations and Strategic Finance. Please go ahead.